{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T05:04:45Z","timestamp":1789275885120,"version":"build-2803163510"},"reference-count":44,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"LabUM Chimie of the University of Montpellier"},{"id":[{"id":"https:\/\/ror.org\/051escj72","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"National Research Agency","doi-asserted-by":"publisher","award":["ANR-16-IDEX-0006"],"award-info":[{"award-number":["ANR-16-IDEX-0006"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"award":["ANR-16-IDEX-0006"],"award-info":[{"award-number":["ANR-16-IDEX-0006"]}],"id":[{"id":"https:\/\/ror.org\/00rbzpz17","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Nationale contre le Cancer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/00rkrv905","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Background\/Objectives: Hybrid microparticles (HMP) based on silylated vegetable oils have recently emerged as promising carriers for the sustained delivery of poorly water-soluble drugs, offering a controlled release without a burst effect and excellent biocompatibility. However, their limited degradability and the acidic conditions required for the sol\u2013gel encapsulation process restrict their biomedical applicability, particularly for acid-sensitive active compounds. The aim of the present study was to develop new degradable vegetable oil-based HMP with improved drug-solubilization capacity while preserving compatibility with acid-sensitive molecules through an adapted mild sol\u2013gel process, buffered with sodium citrate. Methods: Two new modified oils were synthesized from castor oil derivatives, including a monoglyceride (glyceryl monoricinoleate) and a polylactic acid (PLA) conjugate, to enhance both solubilization capacity and degradability. The acid-sensitive, lipophilic antitumor compound JMV5038 was used as a model drug. Modified oils were evaluated for drug-solubilization capacity, and the resulting HMPs were characterized for particle size, encapsulation efficiency, in vitro release kinetics, cytocompatibility, antiproliferative activity against melanoma cells, and in vitro enzymatic degradability. The sol\u2013gel protocol was optimized to minimize drug degradation during encapsulation. Results: Microparticles (20\u2013111 \u00b5m) exhibited a hybrid composition with efficient cross-linking. Encapsulation efficiencies of 85\u2013100% were achieved, aided by up to 10-fold higher drug solubility in the new oils compared to original ICOe. Release kinetics were sustained and linear (11\u201353 days), fastest for IGRe- and slowest for ICOLAe-based HMP. Enzymatic degradation reached up to 46% after 30 days in the presence of fungal lipases, twofold higher than previously published ICOe microparticles, with ICOLAe degrading fastest due to PLA incorporation. Encapsulated JMV5038 retained its cytotoxic efficacy against A375 melanoma cells. Conclusions: These results highlight the promising use of such microparticles as versatile carriers for the prolonged release of lipophilic and acid-sensitive drugs.<\/jats:p>","DOI":"10.3390\/pharmaceutics18091145","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:17:42Z","timestamp":1789114662000},"page":"1145","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of Degradable Silylated Castor Oil-Based Microparticles for the Sustained Release of a Lipophilic Anti-Cancer Drug"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1173-5633","authenticated-orcid":false,"given":"Lucas M.","family":"Favre","sequence":"first","affiliation":[{"name":"Institut des Biomol\u00e9cules Max Mousseron (IBMM),  Univ Montpellier, CNRS, ENSCM, Montpellier, France"},{"name":"Institut Charles Gerhardt Montpellier (ICGM), Univ Montpellier, CNRS, ENSCM, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Ezechiel","family":"Romone","sequence":"additional","affiliation":[{"name":"Institut des Biomol\u00e9cules Max Mousseron (IBMM),  Univ Montpellier, CNRS, ENSCM, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5440-9165","authenticated-orcid":false,"given":"Pierre","family":"Cuq","sequence":"additional","affiliation":[{"name":"Institut des Biomol\u00e9cules Max Mousseron (IBMM),  Univ Montpellier, CNRS, ENSCM, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9169-8149","authenticated-orcid":false,"given":"Nicolas","family":"Masurier","sequence":"additional","affiliation":[{"name":"Institut des Biomol\u00e9cules Max Mousseron (IBMM),  Univ Montpellier, CNRS, ENSCM, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"given":"Anne","family":"Aubert-Pou\u00ebssel","sequence":"additional","affiliation":[{"name":"Institut Charles Gerhardt Montpellier (ICGM), Univ Montpellier, CNRS, ENSCM, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/17460441.2020.1691995","article-title":"Is There Enough Focus on Lipophilicity in Drug Discovery?","volume":"15","author":"Lobo","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","article-title":"Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings","volume":"64","author":"Lipinski","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Da Silva, R.Y.P., de Menezes, D.L.B., Oliveira, V.d.S., Converti, A., and de Lima, \u00c1.A.N. (2023). Microparticles in the Development and Improvement of Pharmaceutical Formulations: An Analysis of In Vitro and In Vivo Studies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065441"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Arun, Y., Ghosh, R., and Domb, A.J. (2021). Biodegradable Hydrophobic Injectable Polymers for Drug Delivery and Regenerative Medicine. Adv. Funct. Mater., 31.","DOI":"10.1002\/adfm.202010284"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/10010146","article-title":"Biodegradable Polymers for Microencapsulation of Drugs","volume":"10","author":"Park","year":"2005","journal-title":"Molecules"},{"key":"ref_6","first-page":"1","article-title":"Studies on Microencapsulation of 5-Fluorouracil with Poly(Ortho Ester) Polymers","volume":"17","author":"Lin","year":"2000","journal-title":"J. Microencapsul."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1081\/PDT-120017521","article-title":"In Vitro Characterization of Polyorthoester Microparticles Containing Bupivacaine","volume":"8","author":"Deng","year":"2003","journal-title":"Pharm. Dev. Technol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1023\/A:1018929531410","article-title":"Controlled Delivery Systems for Proteins Using Polyanhydride Microspheres","volume":"10","author":"Tabata","year":"1993","journal-title":"Pharm. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0169-409X(03)00039-5","article-title":"Biodegradable Polyphosphazenes for Drug Delivery Applications","volume":"55","author":"Lakshmi","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1080\/10717544.2021.1938756","article-title":"PLGA-Based Biodegradable Microspheres in Drug Delivery: Recent Advances in Research and Application","volume":"28","author":"Su","year":"2025","journal-title":"Drug Deliv."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Douf\u00e8ne, K., Basile, I., Lebrun, A., Pirot, N., Escande, A., Chopineau, J., Devoisselle, J.-M., Bettache, N., and Aubert-Pou\u00ebssel, A. (2021). Vegetable Oil-Based Hybrid Microparticles as a Green and Biocompatible System for Subcutaneous Drug Delivery. Int. J. Pharm., 592.","DOI":"10.1016\/j.ijpharm.2020.120070"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Douf\u00e8ne, K., Lapinte, V., Gaveau, P., F\u00e9lix, G., Cacciaguerra, T., Chopineau, J., Robin, J.-J., Devoisselle, J.-M., and Aubert-Pou\u00ebssel, A. (2019). Tunable Vegetable Oil\/Silica Hybrid Microparticles for Poorly Water-Soluble Drug Delivery. Int. J. Pharm., 567.","DOI":"10.1016\/j.ijpharm.2019.118478"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.xphs.2020.10.019","article-title":"Vegetable Oil-Based Hybrid Submicron Particles Loaded with JMV5038: A Promising Formulation against Melanoma","volume":"110","author":"Malki","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1021\/acssuschemeng.7b00369","article-title":"Cross-Linked Castor Oil-Based Hybrid Microparticles as Drug Delivery Systems","volume":"5","author":"Gallon","year":"2017","journal-title":"ACS Sustain. Chem. Eng."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11095-008-9699-8","article-title":"Prolonged Local Anesthetic Action Through Slow Release from Poly(Lactic Acid Co Castor Oil)","volume":"26","author":"Golovanevski","year":"2009","journal-title":"Pharm. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1007\/s11095-011-0497-3","article-title":"Long-Acting Poly(DL:Lactic Acid-Castor Oil) 3:7-Bupivacaine Formulation: Effect of Hydrophobic Additives","volume":"28","author":"Golovanevski","year":"2011","journal-title":"Pharm. Res."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ghitman, J., Stan, R., Ghebaur, A., Cecoltan, S., Vasile, E., and Iovu, H. (2018). Novel PEG-Modified Hybrid PLGA-Vegetable Oils Nanostructured Carriers for Improving Performances of Indomethacin Delivery. Polymers, 10.","DOI":"10.3390\/polym10060579"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1039\/D4TB02648A","article-title":"Vegetable Oil-Derived Functional Polymers in Biomedical Applications: Hurdles and Possibilities","volume":"13","author":"Ghosh","year":"2025","journal-title":"J. Mater. Chem. B"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Favre, L.M., Masurier, N., and Aubert-Pou\u00ebssel, A. (2026). Vegetable Oil-Based Materials for Drug Delivery Systems and Wound Dressings. Macromol. Biosci., 26.","DOI":"10.1002\/mabi.202500486"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s44222-024-00161-w","article-title":"Subcutaneous Drug Delivery from Nanoscale Systems","volume":"2","author":"Tomasini","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"ref_21","unstructured":"(2024, July 29). Melanoma Survival Rates | Melanoma Survival Statistics. Available online: https:\/\/www.cancer.org\/cancer\/types\/melanoma-skin-cancer\/detection-diagnosis-staging\/survival-rates-for-melanoma-skin-cancer-by-stage.html."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Lopes, J., Rodrigues, C.M.P., Gaspar, M.M., and Reis, C.P. (2022). Melanoma Management: From Epidemiology to Treatment and Latest Advances. Cancers, 14.","DOI":"10.3390\/cancers14194652"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbcan.2019.02.002","article-title":"Many Ways to Resistance: How Melanoma Cells Evade Targeted Therapies","volume":"1871","author":"Kozar","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_24","first-page":"744","article-title":"Resistance Mechanisms in Melanoma to Immuneoncologic Therapy with Checkpoint Inhibitors","volume":"2","author":"Fenton","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Eddy, K., Shah, R., and Chen, S. (2021). Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.626129"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.trecan.2020.05.009","article-title":"Clinical Development of BRAF plus MEK Inhibitor Combinations","volume":"6","author":"Subbiah","year":"2020","journal-title":"Trends Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s43556-026-00425-4","article-title":"BRAF Inhibitor Resistance in Melanoma: From Resistance Mechanisms to Therapeutic Innovations","volume":"7","author":"Shang","year":"2026","journal-title":"Mol. Biomed."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ejmech.2014.01.044","article-title":"Imidazopyridine-Fused [1,3]-Diazepinones: Synthesis and Antiproliferative Activity","volume":"75","author":"Gallud","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.ejmech.2016.11.023","article-title":"Imidazopyridine-Fused [1,3]-Diazepinones Part 2: Structure-Activity Relationships and Antiproliferative Activity against Melanoma Cells","volume":"125","author":"Bellet","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1080\/14756366.2020.1748024","article-title":"Imidazopyridine-Fused [1,3]Diazepinones: Modulations of Positions 2 to 4 and Their Impacts on the Anti-Melanoma Activity","volume":"35","author":"Malki","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00289-022-04160-y","article-title":"A Review on Poly Lactic Acid (PLA) as a Biodegradable Polymer","volume":"80","author":"Taib","year":"2023","journal-title":"Polym. Bull."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1021\/jo300364d","article-title":"Selective C-Acylation of 2-Aminoimidazo[1,2-a]Pyridine: Application to the Synthesis of Imidazopyridine-Fused [1,3]Diazepinones","volume":"77","author":"Masurier","year":"2012","journal-title":"J. Org. Chem."},{"key":"ref_33","unstructured":"OECD (1995). Test No. 107: Partition Coefficient (N-Octanol\/Water): Shake Flask Method. OECD Guidelines for the Testing of Chemicals, Section 1, OECD Publishing."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/pj.2016.11","article-title":"Synthesis and Properties of Novel Network Polymers Containing Castor Oil and Silsesquioxane Moieties","volume":"48","author":"Uchida","year":"2016","journal-title":"Polym. J."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Brinker, C.J., and Scherer, G.W. (1990). CHAPTER 3\u2014Hydrolysis and Condensation II: Silicates. Sol-Gel Science, Academic Press.","DOI":"10.1016\/B978-0-08-057103-4.50008-8"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/cplu.201900509","article-title":"Biocompatible Glycine-Assisted Catalysis of the Sol-Gel Process: Development of Cell-Embedded Hydrogels","volume":"84","author":"Valot","year":"2019","journal-title":"ChemPlusChem"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jbm.820050305","article-title":"Biodegradable Poly(Lactic Acid) Polymers","volume":"5","author":"Kulkarni","year":"1971","journal-title":"J. Biomed. Mater. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.xphs.2016.11.014","article-title":"Role of Buffers in Protein Formulations","volume":"106","author":"Zbacnik","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-5173(99)00152-0","article-title":"Instability, Stabilization, and Formulation of Liquid Protein Pharmaceuticals","volume":"185","author":"Wang","year":"1999","journal-title":"Int. J. Pharm."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"10829","DOI":"10.1021\/acsnano.4c14098","article-title":"Buffer Specificity of Ionizable Lipid Nanoparticle Transfection Efficiency and Bulk Phase Transition","volume":"19","author":"Carucci","year":"2025","journal-title":"ACS Nano"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1016\/j.polymer.2014.06.032","article-title":"Electrospun Poly Lactic Acid (PLA) Fibres: Effect of Different Solvent Systems on Fibre Morphology and Diameter","volume":"55","author":"Casasola","year":"2014","journal-title":"Polymer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0378-5173(85)90064-X","article-title":"Polylactic Acid Nanoparticles, a Colloidal Drug Delivery System for Lipophilic Drugs","volume":"27","author":"Krause","year":"1985","journal-title":"Int. J. Pharm."},{"key":"ref_43","first-page":"2213","article-title":"A Plastic Stabilizer Dibutyltin Dilaurate Induces Subchronic Neurotoxicity in Rats","volume":"7","author":"Jin","year":"2012","journal-title":"Neural Regen. Res."},{"key":"ref_44","unstructured":"(2026, July 15). Center for Drug Evaluation and Research Q3D(R2)\u2014Guideline for Elemental Impurities, Available online: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/q3dr2-guideline-elemental-impurities."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/9\/1145\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T04:14:20Z","timestamp":1789272860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/9\/1145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":44,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["pharmaceutics18091145"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics18091145","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}